IMMNOV Share Price Performance
SEK 0.25
-0.41 (-62.25%)
66.0% undervalued intrinsic discount
SEK 0.73
Fair Value
Price SEK 0.25
AnalystConsensusTarget SEK 0.73
Fair ValueSEK 0.73
Share Pricen/a
Immunovia AB (publ) Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
IMMNOV Community Narratives
AN
Fair Value SEK 0.73 66.0% undervalued intrinsic discount
Blood Cancer Screening Adoption Will Drive Long-Term Upside Potential
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Blood Cancer Screening Adoption Will Drive Long-Term Upside Potential
Catalysts About Immunovia Immunovia develops and commercializes blood based diagnostic tests for the early detection of pancreatic cancer. What are the underlying business or industry changes driving this perspective?Read more
0
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
SEK 0.73
66.0% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
295.03% p.a.
Profit Margin
8.07%
Future PE
83.31x
Price in 2028
SEK 0.48
Trending Discussion
Recently Updated Narratives
AN
Blood Cancer Screening Adoption Will Drive Long-Term Upside Potential
Fair Value: SEK 0.73 66.0% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Immunovia AB (publ) Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 24, 2026
- -0.19
- 95.42%
- -15,968.96%
- 0%
About IMMNOV
- Founded
- 2007
- Employees
- 12
- CEO
- WebsiteView website
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
